Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome

American Journal of Medicine

Volumn 106, Issue 5, 1999, Pages 534-543

  Adler, Gail K ^a,d   Kinsley, Brendan T ^a   Hurwitz, Shelley ^a   Mossey, Christopher J ^b,c   Goldenberg, Don L ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NEWTON WELLESLEY HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; CORTICOTROPIN; GLUCOSE; HYDROCORTISONE; INSULIN; NORADRENALIN; PLACEBO; PRASTERONE; PROLACTIN; TETRACOSACTIDE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; FIBROMYALGIA; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERINSULINEMIA; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; PREMENOPAUSE; PRIORITY JOURNAL;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ADULT; CASE-CONTROL STUDIES; DEHYDROEPIANDROSTERONE; EPINEPHRINE; FEMALE; FIBROMYALGIA; HORMONES; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NOREPINEPHRINE; PROLACTIN; TIME FACTORS;

EID: 0033134687     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00074-1     Document Type: Article

References (39)

1. Goldenberg D.L. Fibromyalgia syndrome. JAMA. 257:1987;2782-2787.
2. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia report of the Multicenter Criteria Committee . Arthritis Rheum. 33:1990;160-172.
3. Wolfe F., Ross K., Anderson J., Russell I.J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 38:1995;19-28.
4. Kalyan-Raman U.P., Kalyan-Raman K., Yunus M.B., Masi A.T. Muscle pathology in primary fibromyalgia syndrome a light microscopic, histochemical and ultrastructural study . J Rheumatol. 11:1984;808-813.
5. Simms R.W., Roy S.H., Hrovar M., et al. Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum. 37:1994;794-800.
6. Magiakou M.A., Chrousos G.P. Corticosteroid therapy, nonendocrine disease, and corticosteroid withdrawal. Curr Ther Endocrinol Metab. 5:1994;120-124.
7. Brigell D.F., Fang V.S., Rosenfield R.L. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoids. J Clin Endocrinol Metab. 74:1992;1036-1039.
8. Crofford L.J., Engleberg N.C., Demitrack M.A. Neurohormonal perturbations in fibromyalgia. Baillieres Clin Rheumatol. 10:1996;365-378.
9. Crofford L.J., Pillemer S.R., Kalogeras K.T., et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 11:1994;1583-1592.
10. McCain G.A., Tilbe K.S. Diurnal hormone variation in fibromyalgia syndrome a comparison with rheumatoid arthritis . J Rheumatol. 19:1989;154-157.
11. Griep E.N., Boersma J.W., de Kloet E.R. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol. 20:1993;469-474.
12. Van Denderen J.C., Boersma J.W., Zeinstra P., Hollander A.P., van Neerbos B.R. Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS) is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol. 21:1992;35-37.
13. Mengshoel A.M., Saugen E., Forre O., Vollestad N.K. Muscle fatigue in early fibromyalgia. J Rheumatol. 22:1995;143-150.
14. Yunus M.B., Dailey J.W., Aldag J.C., Masi A.T., Jobe P.C. Plasma and urinary catecholamines in primary fibromyalgia a controlled study . J Rheumatol. 19:1992;95-97.
15. Russell J., Vipraio G.A., Morgan W.W., Bowden C.L. Is there a metabolic basis for the fibrositis syndrome? Am J Med. 81:(suppl 3A):1986;50-54.
16. Ferraccioli G., Cavalieri F., Salaffi F., et al. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J Rheumatol. 17:1990;869-873.
17. Clark S., Tindall E., Bennett R.M. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol. 12:1985;980-983.
18. Burckhardt C.S., Clark S.R., Bennett R.M. The fibromyalgia impact questionnaire development and validation . J Rheumatol. 18:1991;728-733.
19. McGuire E.A., Helderman J.H., Tobin J.D., Andres R., Berman M. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol. 41:1976;565-573.
20. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique a method for quantifying insulin secretion and resistance . Am J Physiol. 237:1979;E213-E223.
21. Peuler J.D., Johnson G.A. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 21:1977;625-636.
22. Sunderman F.W. Jr. Measurement of urinary corticosteroids; modified Porter-Silber method. Sunderman F., Sunderman F.W. Jr, . Lipids and Steroid Hormones in Clinical Medicine. 1960;162-164 Lippincott, Philadelphia.
23. Silber R.H., Porter C.C. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma. J Biol Chem. 210:1954;923-932.
24. Litchfield W.R., Hunt S.C., Jeunemaitre X., et al. Increased urinary free cortisol a potential intermediate phenotype of essential hypertension . Hypertension. 31:1998;569-574.
25. Greenhouse S.W., Geisser S. On methods in the analysis of profile data. Psychometrika. 32:1959;95-112.
26. Purves R.D. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). J Pharmacokinet Biopharm. 20:1992;211-226.
27. Sherwin R.S. Evaluation of hypoglycemic counterregulation using a modification of the andres glucose clamp. Exp Gerontol. 28:1993;371-380.
28. Kvetnansky R., Pacak K., Fukuhara K., et al. Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann NY Acad Sci. 771:1995;131-158.
29. Herman J.P., Cullinan W.E. Neurocircuitry of stress central control of the hypothalamo-pituitary-adrenocortical axis . Trends Neurosci. 20:1997;78-84.
30. Valentino R.J., Page M., Van Bockstaele E., Aston-Jones G. Corticotropin-releasing factor innervation of the locus coeruleus region distribution of fibers and sources of input . Neuroscience. 48:1992;689-705.
31. Goldstein D.S., Pacak K., Kopin I.J. Nonspecificity versus primitive specificity of stress responses. McCarty R., Aguilera G., Sabban E., Kvetnansky R., Stress Molecular Genetic and Neurobiological Advances . 1996;3-20 Harwood Academic Publishers, Amsterdam, The Netherlands.
32. Kita A., Imano K., Nakamura H. Involvement of corticotropin-releasing factor in the antinociception produced by interleukin-1 in mice. Eur J Pharmacol. 237:1993;317-322.
33. McDermid A.J., Rollman G.B., McCain G.A. Generalized hypervigilance in fibromyalgia evidence of perceptual amplification . Pain. 66:1996;133-144.
34. Heinrichs S.C., Menzaghi F., Pich E.M., Britton K.T., Koob G.F. The role of CRF in behavioral aspects of stress. Annals NY Acad Sci. 771:1995;92-104.
35. Bou-Holaigah I., Calkins H., Flynn J.A., et al. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol. 15:1997;239-246.
36. Goldenberg D.L. Fibromyalgia why such controversy? Ann Rheum Dis. 54:1995;3-5.
37. Cohen M.L., Quintner J.L. Fibromyalgia syndrome, a problem of tautology. Lancet. 342:1993;8876.
38. Goldenberg D.L., Simms R.W., Geiger A., Komaroff A.L. High frequency of fibromyalgia in patients with chronic fatigue seen in primary care practice. Arthritis Rheum. 33:1990;381-387.
39. Hudson J.I., Goldenberg D.L., Pope H.G. Jr, Keck P.E. Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 92:1992;363-367.